Saltar a la navegació principal
Saltar a la cerca
Vés al contingut principal
Acrònim zwiRNA Estatus Acabat Data efectiva d'inici i finalització 1/09/22 → 31/08/25
Nanoparticle
Pharmacology, Toxicology and Pharmaceutical Science
100%
Malignant Neoplasm
Pharmacology, Toxicology and Pharmaceutical Science
39%
Lipid
Pharmacology, Toxicology and Pharmaceutical Science
39%
Messenger RNA
Biochemistry, Genetics and Molecular Biology
39%
Nanocarrier
Pharmacology, Toxicology and Pharmaceutical Science
27%
Gene Delivery
Pharmacology, Toxicology and Pharmaceutical Science
26%
Nucleic Acid
Pharmacology, Toxicology and Pharmaceutical Science
20%
Rheumatoid Arthritis
Pharmacology, Toxicology and Pharmaceutical Science
19%